Healthcare - Biotechnology - NASDAQ - GB
$ 35.66
0.82 %
$ 2.92 B
Market Cap
-18.67
P/E
Price Target
Average
6.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--15.40%
Net Income
Estimate
40.01%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Verona Pharma plc
Wall Street analysts predict an average 1-year price target for VRNA of $37.8 , with forecasts ranging from a low of $36 to a high of $42 .
VRNA Lowest Price Target
Wall Street Target
36 USD
0.95%
VRNA Average Price Target
Wall Street Target
37.8 USD
6.00%
VRNA Highest Price Target
Wall Street Target
42 USD
17.78%
REVENUE FORECAST
Revenue Forecast Chart VRNA
EBIT FORECAST
EBIT Forecast Chart VRNA
NET INCOME FORECAST
Net Income Chart VRNA